GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy

Lemke JR, Hendrickx R, Geider K, Laube B, Schwake M, Harvey RJ, James VM, Pepler A, Steiner I, Hoertnagel K, Neidhardt J, et al. (2014)
Annals of Neurology 75(1): 147-154.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
Objective: To identify novel epilepsy genes using a panel approach and describe the functional consequences of mutations. Methods: Using a panel approach, we screened 357 patients comprising a vast spectrum of epileptic disorders for defects in genes known to contribute to epilepsy and/or intellectual disability (ID). After detection of mutations in a novel epilepsy gene, we investigated functional effects in Xenopus laevis oocytes and screened a follow-up cohort. Results: We revealed de novo mutations in GRIN2B encoding the NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor in 2 individuals with West syndrome and severe developmental delay as well as 1 individual with ID and focal epilepsy. The patient with ID and focal epilepsy had a missense mutation in the extracellular glutamate-binding domain (p.Arg540His), whereas both West syndrome patients carried missense mutations within the NR2B ion channel-forming re-entrant loop (p.Asn615Ile, p.Val618Gly). Subsequent screening of 47 patients with unexplained infantile spasms did not reveal additional de novo mutations, but detected a carrier of a novel inherited GRIN2B splice site variant in close proximity (c.2011-5_2011-4delTC). Mutations p.Asn615Ile and p.Val618Gly cause a significantly reduced Mg2+ block and higher Ca2+ permeability, leading to a dramatically increased Ca2+ influx, whereas p.Arg540His caused less severe disturbance of channel function, corresponding to the milder patient phenotype. Interpretation: We identified GRIN2B gain-of-function mutations as a cause of West syndrome with severe developmental delay as well as of ID with childhood onset focal epilepsy. Severely disturbed channel function corresponded to severe clinical phenotypes, underlining the important role of facilitated NMDA receptor signaling in epileptogenesis.
Publishing Year
ISSN
PUB-ID

Cite this

Lemke JR, Hendrickx R, Geider K, et al. GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology. 2014;75(1):147-154.
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., et al. (2014). GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology, 75(1), 147-154. doi:10.1002/ana.24073
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., Pepler, A., Steiner, I., Hoertnagel, K., et al. (2014). GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology 75, 147-154.
Lemke, J.R., et al., 2014. GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology, 75(1), p 147-154.
J.R. Lemke, et al., “GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy”, Annals of Neurology, vol. 75, 2014, pp. 147-154.
Lemke, J.R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R.J., James, V.M., Pepler, A., Steiner, I., Hoertnagel, K., Neidhardt, J., Ruf, S., Wolff, M., Bartholdi, D., Caraballo, R., Platzer, K., Suls, A., De Jonghe, P., Biskup, S., Weckhuysen, S.: GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology. 75, 147-154 (2014).
Lemke, Johannes R., Hendrickx, Rik, Geider, Kirsten, Laube, Bodo, Schwake, Michael, Harvey, Robert J., James, Victoria M., Pepler, Alex, Steiner, Isabelle, Hoertnagel, Konstanze, Neidhardt, John, Ruf, Susanne, Wolff, Markus, Bartholdi, Deborah, Caraballo, Roberto, Platzer, Konrad, Suls, Arvid, De Jonghe, Peter, Biskup, Saskia, and Weckhuysen, Sarah. “GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy”. Annals of Neurology 75.1 (2014): 147-154.
This data publication is cited in the following publications:
This publication cites the following data publications:

65 Citations in Europe PMC

Data provided by Europe PubMed Central.

Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J, Cai T, Jiang Y, Chen H, He X, Chen C, Li X, Shao Q, Ran X, Li Z, Xia K, Liu C, Sun ZS, Wu J., Mol Psychiatry 21(2), 2016
PMID: 25849321
Expanding the spectrum of Grik2 mutations: intellectual disability, behavioural disorder, epilepsy and dystonia.
Córdoba M, Rodriguez S, González Morón D, Medina N, Kauffman MA., Clin Genet 87(3), 2015
PMID: 25039795
NMDA receptor subunit mutations in neurodevelopmental disorders.
Burnashev N, Szepetowski P., Curr Opin Pharmacol 20(), 2015
PMID: 25498981
Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.
Hardies K, May P, Djémié T, Tarta-Arsene O, Deconinck T, Craiu D, AR working group of the EuroEPINOMICS RES Consortium, Helbig I, Suls A, Balling R, Weckhuysen S, De Jonghe P, Hirst J., Hum Mol Genet 24(8), 2015
PMID: 25552650
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.
Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF., Mol Pharmacol 88(1), 2015
PMID: 25904555
Epilepsy genetics: the ongoing revolution.
Lesca G, Depienne C., Rev Neurol (Paris) 171(6-7), 2015
PMID: 26003806
Clinical Genetic Testing in Epilepsy.
Mefford HC., Epilepsy Curr 15(4), 2015
PMID: 26316867
Glutamate receptor mutations in psychiatric and neurodevelopmental disorders.
Soto D, Altafaj X, Sindreu C, Bayés A., Commun Integr Biol 7(1), 2014
PMID: 24605182
Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.
Adams DR, Yuan H, Holyoak T, Arajs KH, Hakimi P, Markello TC, Wolfe LA, Vilboux T, Burton BK, Fajardo KF, Grahame G, Holloman C, Sincan M, Smith AC, Wells GA, Huang Y, Vega H, Snyder JP, Golas GA, Tifft CJ, Boerkoel CF, Hanson RW, Traynelis SF, Kerr DS, Gahl WA., Mol Genet Metab 113(3), 2014
PMID: 24863970
Harnessing gene expression networks to prioritize candidate epileptic encephalopathy genes.
Oliver KL, Lukic V, Thorne NP, Berkovic SF, Scheffer IE, Bahlo M., PLoS One 9(7), 2014
PMID: 25014031
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium., Am J Hum Genet 95(4), 2014
PMID: 25262651
De novo mutations in moderate or severe intellectual disability.
Hamdan FF, Srour M, Capo-Chichi JM, Daoud H, Nassif C, Patry L, Massicotte C, Ambalavanan A, Spiegelman D, Diallo O, Henrion E, Dionne-Laporte A, Fougerat A, Pshezhetsky AV, Venkateswaran S, Rouleau GA, Michaud JL., PLoS Genet 10(10), 2014
PMID: 25356899

30 References

Data provided by Europe PubMed Central.

Evidence for a tetrameric structure of recombinant NMDA receptors.
Laube B, Kuhse J, Betz H., J. Neurosci. 18(8), 1998
PMID: 9526012
Molecular basis of NMDA receptor functional diversity.
Paoletti P., Eur. J. Neurosci. 33(8), 2011
PMID: 21395862
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM., Lancet 380(9854), 2012
PMID: 23020937
The NMDA receptor complex as a therapeutic target in epilepsy: a review.
Ghasemi M, Schachter SC., Epilepsy Behav 22(4), 2011
PMID: 22056342

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 24272827
PubMed | Europe PMC

Search this title in

Google Scholar